Cbl Biopharma LLC is categorized under Wholesale Pharmaceutical Products in Boulder, CO and active since 2008.
Cbl Biopharma LLC was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Gary W Erickson at the company’s single location by writing to 3015 Sterling Circle # 200, Boulder, Colorado CO 80301 or by phoning (303) 317-3516. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cbl Biopharma LLC |
| Contact Person: | Gary W Erickson |
| Address: | 3015 Sterling Circle # 200, Boulder, Colorado 80301 |
| Phone Number: | (303) 317-3516 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Cbl Biopharma LLC was started in 2008 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gary W Erickson for inquiries that concern Cbl Biopharma LLC by calling the company number (303) 317-3516, as your correspondence is most welcome. Additionally, the physical location of the single location of Cbl Biopharma LLC can be found at the coordinates 40.029785,-105.22787 as well as the street address 3015 Sterling Circle # 200 in Boulder, Colorado 80301.
For its online presence, you may visit Cbl Biopharma LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.